IRIS
GIUDICE, GIULIA CLAIRE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.115
NA - Nord America 842
EU - Europa 539
SA - Sud America 145
AF - Africa 61
OC - Oceania 4
Totale 2.706
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 805
SG - Singapore 409
VN - Vietnam 195
IT - Italia 185
CN - Cina 180
BD - Bangladesh 118
BR - Brasile 110
HK - Hong Kong 84
DE - Germania 76
FR - Francia 66
ZA - Sudafrica 50
NL - Olanda 46
IN - India 30
GB - Regno Unito 28
CA - Canada 22
FI - Finlandia 21
JP - Giappone 19
IE - Irlanda 18
RU - Federazione Russa 16
DK - Danimarca 14
SE - Svezia 13
AR - Argentina 12
AT - Austria 11
KR - Corea 11
EC - Ecuador 8
ID - Indonesia 8
IQ - Iraq 8
MY - Malesia 8
PH - Filippine 8
TR - Turchia 7
ES - Italia 6
MX - Messico 6
PL - Polonia 6
BE - Belgio 5
HU - Ungheria 5
PK - Pakistan 5
UZ - Uzbekistan 5
AU - Australia 4
CH - Svizzera 4
CO - Colombia 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
IR - Iran 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
CL - Cile 3
MA - Marocco 3
PE - Perù 3
VE - Venezuela 3
AZ - Azerbaigian 2
BG - Bulgaria 2
EG - Egitto 2
IL - Israele 2
KE - Kenya 2
LT - Lituania 2
LV - Lettonia 2
PA - Panama 2
PT - Portogallo 2
SA - Arabia Saudita 2
TW - Taiwan 2
AO - Angola 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
LB - Libano 1
MC - Monaco 1
PS - Palestinian Territory 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
UA - Ucraina 1
YE - Yemen 1
Totale 2.706
Salva come PNG Salva come JPEG
Città #
Singapore 264
Ashburn 183
San Jose 128
Santa Clara 95
Hong Kong 76
Ho Chi Minh City 55
Hanoi 49
Johannesburg 46
New York 44
Boardman 42
Beijing 37
Munich 35
Los Angeles 34
Dallas 30
Lauterbourg 22
Marseille 20
Buffalo 17
Hefei 16
Dublin 15
Haiphong 15
Milan 15
Frankfurt am Main 14
Amsterdam 13
Rome 13
Aarhus 12
Da Nang 11
Düsseldorf 11
Montreal 11
Parma 11
Shanghai 11
Council Bluffs 10
Helsinki 9
Naples 9
Orem 9
Osaka 9
São Paulo 9
Chennai 8
Jinan 8
London 8
Moscow 8
Nuremberg 8
Tokyo 8
Turku 8
Sassuolo 7
Vienna 7
Bologna 6
Denver 6
Ninh Bình 6
Paris 6
San Francisco 6
Budapest 5
Cavriago 5
Florence 5
Seoul 5
Stockholm 5
Tashkent 5
Warsaw 5
Bengaluru 4
Brussels 4
Chiari 4
Chicago 4
Kitzingen 4
Melbourne 4
Palermo 4
Poplar 4
Portsmouth 4
Prague 4
Quito 4
Sungai Petani 4
Trento 4
Venice 4
Atlanta 3
Bexley 3
Brasília 3
Brooklyn 3
Buenos Aires 3
Charlotte 3
City of London 3
Collecchio 3
Erbil 3
Guayaquil 3
Lahore 3
Modena 3
Paderno Dugnano 3
Rio de Janeiro 3
Rocca Priora 3
San José 3
Solna 3
Surabaya 3
Thái Nguyên 3
Ankara 2
Baku 2
Bauru 2
Belo Horizonte 2
Bismarck 2
Biên Hòa 2
Cagliari 2
Cairo 2
Campo Grande 2
Can Tho 2
Totale 1.668
Salva come PNG Salva come JPEG
Nome #
LBA77 Fecal microbiota transplantation (FMT) versus placebo in patients receiving pembrolizumab plus axitinib for metastatic renal cell carcinoma: Preliminary results of the randomized phase II TACITO trial 280
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 151
2125P Potential ROle of hypoVItaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): A prospective observational study 144
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 135
Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project 130
The effect of concomitant drugs on oncological outcomes in patients treated with immunotherapy for metastatic urothelial carcinoma: a narrative review 130
External Validation of the GRade, Age, Nodes and Tumor (GRANT) Score for Patients with Surgically Treated Papillary Renal Cell Carcinoma 124
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score 123
Potential ROle of hypovitaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): a prospective observational study. 119
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario 115
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy 113
Successful treatment with selpercatinib after pralsetinib-related pneumonitis and intracranial failure in a patient with RET-rearranged nonsmall cell lung cancer 111
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study 102
The distinct prognostic impact of circulating lipid profile according to neutrophil to lymphocyte ratio in patients with advanced solid tumors treated with immune check point inhibitors. 92
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome? 91
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors 91
Comparing the prognostic models to predict oncologic outcomes in patients with renal cell carcinoma: is AUC close enough to clinical practice? 90
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study 89
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9) 89
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study) 88
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study 76
Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney 74
Comparing a Part with the Whole: Beware of the Disparity of the Renal Cell Carcinoma Prognostic Models 69
Wolf in sheep's clothing or not? The pT1 LG dilemma 54
Treatment of metastatic TFE3 microphthalmia transcription factor translocation renal cell carcinoma: a case report 46
A prospective external validation of the GRade, Age, Nodes and Tumor score in the ECOG-ACRIN EA8143 PROSPER trial 6
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial 3
Totale 2.735
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.081
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226 0 0 0 0 0 0 0 0 0 5 0 1
2022/202319 2 1 1 0 0 1 0 0 13 0 1 0
2023/2024119 0 24 9 2 5 10 12 1 12 8 6 30
2024/2025763 14 57 56 33 58 88 44 36 65 87 73 152
2025/20261.828 160 116 193 157 247 117 170 71 184 130 168 115
Totale 2.735